Ligand validation:5QDU

GV1: ~{N},~{N},5,6-tetramethylthieno[2,3-d]pyrimidin-4-amine

GV1 is a Ligand Of Interest in 5QDU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QDU_GV1_A_401	0%	6%	0.807	0.44	2.9	2.21	4	2	0	0	100%	11
5QDU_GV1_A_404	0%	7%	1.111	0.517	2.68	2.08	4	1	2	0	100%	11
5QDU_GV1_A_403	0%	8%	0.925	0.219	2.99	1.67	4	1	3	0	100%	11
5QDU_GV1_A_402	0%	8%	1.23	0.322	2.97	1.65	4	1	5	0	100%	11
7GS8_GV1_A_401	3%	4%	0.409	0.737	3.17	2.4	4	3	0	0	100%	0.48
5RHW_GV1_A_705	32%	8%	0.197	0.869	3.16	1.49	3	1	0	0	100%	0.6
5QI4_GV1_A_1404	10%	16%	0.241	0.747	2	1.68	2	3	0	0	100%	0.48
5R5E_GV1_A_401	4%	17%	0.39	0.782	2.39	1.24	3	1	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.